Global HIV Vaccine Enterprise Releases 2018-2023 Strategic Plan

International AIDS Society: Global HIV Vaccine Enterprise: Strategic Plan
The Global HIV Vaccine Enterprise (the Enterprise), hosted by IAS, released its 2018-2023 strategic plan, which aims to address several questions: “How can we maintain the momentum of scientific collaborative efforts while orienting the vaccine community around emerging priorities in late-stage product development? How can we support the vaccine space to respond optimally to results from current efficacy trials? How can we best leverage the IAS’ track record in convening and engaging a diverse range of stakeholders to advance the interests of the HIV vaccine community? How can we heighten political support and expand the Enterprise?” (October 2018).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.